Recommendations for the programme of clinical trials of medicinal products for the treatment of influenza
Scientific relevance. The development of new medicinal products to treat influenza is motivated by the limitations of existing treatment options, the emergence of drug resistance, and the health consequences of influenza epidemics associated with the highly contagious nature of the virus. Proper pla...
Saved in:
| Main Authors: | A. I. Gubenko, G. V. Shukshina, A. I. Muravieva, N. E. Uvarova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2023-12-01
|
| Series: | Регуляторные исследования и экспертиза лекарственных средств |
| Subjects: | |
| Online Access: | https://www.vedomostincesmp.ru/jour/article/view/400 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recommendations for the Clinical Development of Medicinal Products for Non-specific Influenza Chemoprophylaxis
by: A. I. Gubenko, et al.
Published: (2024-04-01) -
nucleoside analogues for the treatment of influenza: history and experience
by: K. V. Kasianenko, et al.
Published: (2019-10-01) -
Meta-analysis of randomized clinical trials of Riamilovir efficacy in etiotropic therapy of influenza
by: A. U. Sabitov, et al.
Published: (2021-08-01) -
Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial
by: A. V. Averyanov, et al.
Published: (2020-05-01) -
Mouse-adapted influenza B virus for in vitro and in vivo assessment of therapeutic and preventive efficacy of antiviral drugs
by: E. A. Prokopyeva, et al.
Published: (2019-12-01)